These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2893314)

  • 21. No response to high-dose muscarinic agonist therapy in Alzheimer's disease.
    Mouradian MM; Mohr E; Williams JA; Chase TN
    Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders.
    Harbaugh RE
    Neurobiol Aging; 1989; 10(5):623-9. PubMed ID: 2572986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).
    Wettstein A; Spiegel R
    Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.
    Thanik K; Chey WY; Shak A; Hamilton D; Nadelson N
    Arch Intern Med; 1982 Aug; 142(8):1479-81. PubMed ID: 6125135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bethanechol in the treatment of stuttering.
    Kampman K; Brady JP
    J Clin Psychopharmacol; 1993 Aug; 13(4):284-5. PubMed ID: 8104201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type.
    Raffaele KC; Berardi A; Asthana S; Morris P; Haxby JV; Soncrant TT
    Psychopharmacol Bull; 1991; 27(3):315-9. PubMed ID: 1775605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of oral and parenteral bethanechol on decompensated bladder.
    Diokno AC; Lapides J
    Urology; 1977 Jul; 10(1):23-4. PubMed ID: 327652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study.
    Barrett DM
    J Urol; 1981 Nov; 126(5):640-2. PubMed ID: 6117662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
    Florian H; Meier A; Gauthier S; Lipschitz S; Lin Y; Tang Q; Othman AA; Robieson WZ; Gault LM
    J Alzheimers Dis; 2016; 51(4):1237-47. PubMed ID: 26967214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bethanechol decreases reaction time in senile dementia of the Alzheimer type.
    Davous P; Lamour Y
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1297-9. PubMed ID: 4087006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
    Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN
    Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia.
    Moré MI; Freitas U; Rutenberg D
    Adv Ther; 2014 Dec; 31(12):1247-62. PubMed ID: 25414047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
    Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H
    Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of donepezil in Alzheimer's disease - results from a multinational trial.
    Burns A; Rossor M; Hecker J; Gauthier S; Petit H; Möller HJ; Rogers SL; Friedhoff LT
    Dement Geriatr Cogn Disord; 1999; 10(3):237-44. PubMed ID: 10325453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Decourt B; Drumm-Gurnee D; Wilson J; Jacobson S; Belden C; Sirrel S; Ahmadi M; Shill H; Powell J; Walker A; Gonzales A; Macias M; Sabbagh MN
    Curr Alzheimer Res; 2017; 14(4):403-411. PubMed ID: 28124585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.
    Thal LJ; Schwartz G; Sano M; Weiner M; Knopman D; Harrell L; Bodenheimer S; Rossor M; Philpot M; Schor J; Goldberg A
    Neurology; 1996 Dec; 47(6):1389-95. PubMed ID: 8960716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
    Xiao S; Wang T; Ma X; Qin Y; Li X; Zhao Z; Liu X; Wang X; Xie H; Jiang Q; Sun L; Luo B; Shang L; Chen W; Bai Y; Tang M; He M; Wu L; Ma Q; Hou D; He J
    Age Ageing; 2017 Sep; 46(5):767-773. PubMed ID: 28419192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.